Chemical industry – Page 64
-
BusinessFDA moves to withdraw swine drug carbadox
Carcinogenic antibiotic has been banned in EU, Canada and Australia for years
-
BusinessSurge in US industry investment linked to shale gas
264 expansion or construction projects announced, of which 40% have commenced or completed
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
BusinessDuPont shutters US plant where leak killed four workers
La Porte plant will not reopen after fatal methyl mercaptan leak in 2014
-
BusinessCalifornian hazard warning website criticised
Site providing information related to state’s Proposition 65 law is ‘inaccurate’ says industry association
-
BusinessTwo dead in explosion at Chinese chemical plant
Five others injured when wastewater treatment device detonated
-
OpinionThrowing things over the fence
Saying ‘That’s someone else’s problem’ is asking for trouble, says Derek Lowe
-
BusinessGilead loses to Merck & Co in hepatitis C drug dispute
US court upholds Merck’s claim to patents related to blockbuster drugs
-
BusinessMEGlobal to build $1bn US petrochemical plant
Ethylene glycol company announces plans for first US facility
-
BusinessIndian whistleblower pushes for regulatory reform
Although denied a hearing by India’s supreme court, Dinesh Thakur wants to shake up pharmaceutical safety laws
-
FeatureEnzymes for everyone
Can scientists overcome enzymes’ fragility and exploit their speed and specificity? Fiona Case investigates
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
BusinessIndia bans 344 combination drugs
Manufacturers appeal to courts to allow continued sales of products the government deems risky
-
BusinessSanction lift triggers investment in Iran
Ambitious state plans and openness to foreign companies could combine to revive Iran’s chemical industry
-
OpinionDrugs don’t grow on trees
The trope of companies profiteering from academic discoveries doesn’t bear much scrutiny, says Derek Lowe
-
BusinessSanofi and Merck & Co end vaccines partnership
Two-decade-long alliance will split by end of 2016
-
BusinessExxonMobil sued for Clean Air Act violations
Environmental campaigners claim ExxonMobil’s plant emissions harm local residents
-
BusinessDow to settle polyurethane price-fixing case
Chemical giant cancels Supreme Court appeal of damages and agrees $835m settlement
-
Business
EPA aims to remove flubendiamide pesticide from market
After reassessing environmental impact, the agency wants to withdraw Bayer and Nichino America insecticides
-
OpinionForged in righteous flames
Could the debate over pharma price-gouging have positive results for both patients and companies?